Concord Biotech Ltd Half Yearly Results

Gross Sales

451.05

674.1

525.98

559.77

457.17

Excise Duty

0

0

0

0

0

Net Sales

451.05

674.1

525.98

559.77

457.17

Other Operating Income

0

0

0

0

0

Other Income

30.81

24.11

20.33

19.82

17.33

Total Income

481.86

698.22

546.32

579.59

474.5

Total Expenditure

301.16

385.45

309.63

319.55

265.83

PBIDT

180.7

312.77

236.69

260.04

208.67

Interest

0.12

0.19

0.34

0.96

1.59

PBDT

180.58

312.58

236.35

259.08

207.08

Depreciation

36.17

27.88

26.49

27.26

26.34

Minority Interest Before NP

0

0

0

0

0

Tax

36.07

65.51

53.45

55.78

44.06

Deferred Tax

1.22

2.88

1.07

3.46

1.17

Reported Profit After Tax

107.12

216.31

155.33

172.59

135.51

Minority Interest After NP

-0.52

0

0

0

0

Net Profit after Minority Interest

107.64

216.31

155.33

172.59

135.51

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

107.64

216.31

155.33

172.59

135.51

EPS (Unit Curr.)

10.24

20.68

14.85

16.5

12.95

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.46

10.46

10.46

10.46

10.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

40.06

46.39

44.99

46.45

45.64

PBDTM(%)

-

-

-

-

-

PATM(%)

23.74

32.08

29.53

30.83

29.64